帕金森病运动并发症中西医结合诊治专家共识(2020)

2020-07-20 中国神经免疫学和神经病学杂志.2020.27(4):247-252.

帕金森病(PD)是中老年人常见的神经系统退行性疾病。左旋多巴替代治疗是其最主要的临床治疗方法,因该药在PD疾病后期可诱发运动并发症,严重影响患者的生活质量,故中晚期PD的治疗现已成为重点与难点。目前西

中文标题:

帕金森病运动并发症中西医结合诊治专家共识(2020)

发布机构:

发布日期:

2020-07-20

简要介绍:

帕金森病(PD)是中老年人常见的神经系统退行性疾病。左旋多巴替代治疗是其最主要的临床治疗方法,因该药在PD疾病后期可诱发运动并发症,严重影响患者的生活质量,故中晚期PD的治疗现已成为重点与难点。目前西医和中医治疗PD运动并发症各具优势,西医对于运动并发症的治疗优势体现在临床分型及循证证据较为充分明确,但缺乏对疾病整体治疗的理念,而中医整体观念和辨证论治的理念正是对西医治疗不足的有效补充,两者结合应用可能更好地治疗PD运动并发症。基于此,PD运动并发症中西医结合诊治专家共识写作组秉承“辨识兼顾,防治并举”的诊治理念,综合西医和中医治疗PD运动并发症的各自优势,形成了PD运动并发症中西医结合诊治专家共识,以期为PD运动并发症的临床综合诊疗提供参考。

相关资料下载:
[AttachmentFileName(sort=1, fileName=帕金森病运动并发症中西医结合诊治专.pdf)] GetToolGuiderByIdResponse(projectId=1, id=d01d61c00196886a, title=帕金森病运动并发症中西医结合诊治专家共识(2020), enTitle=, guiderFrom=中国神经免疫学和神经病学杂志.2020.27(4):247-252., authorId=0, author=, summary=帕金森病(PD)是中老年人常见的神经系统退行性疾病。左旋多巴替代治疗是其最主要的临床治疗方法,因该药在PD疾病后期可诱发运动并发症,严重影响患者的生活质量,故中晚期PD的治疗现已成为重点与难点。目前西, cover=https://img.medsci.cn/2020910/1599672031604_2020535.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Jul 20 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>帕金森病(PD)是中老年人常见的神经系统退行性疾病。左旋多巴替代治疗是其最主要的临床治疗方法,因该药在PD疾病后期可诱发运动并发症,严重影响患者的生活质量,故中晚期PD的治疗现已成为重点与难点。目前西医和中医治疗PD运动并发症各具优势,西医对于运动并发症的治疗优势体现在临床分型及循证证据较为充分明确,但缺乏对疾病整体治疗的理念,而中医整体观念和辨证论治的理念正是对西医治疗不足的有效补充,两者结合应用可能更好地治疗PD运动并发症。基于此,PD运动并发症中西医结合诊治专家共识写作组秉承&ldquo;辨识兼顾,防治并举&rdquo;的诊治理念,综合西医和中医治疗PD运动并发症的各自优势,形成了PD运动并发症中西医结合诊治专家共识,以期为PD运动并发症的临床综合诊疗提供参考。</p> </div> </div> </div>, tagList=[TagDto(tagId=337, tagName=帕金森病)], categoryList=[CategoryDto(categoryId=17, categoryName=神经科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=337, guiderKeyword=帕金森病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=2814, appHits=281, showAppHits=0, pcHits=517, showPcHits=2533, likes=2, shares=28, comments=21, approvalStatus=1, publishedTime=Thu Sep 10 01:37:10 CST 2020, publishedTimeString=2020-07-20, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Thu Sep 10 01:20:51 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 12:27:55 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=帕金森病运动并发症中西医结合诊治专.pdf)])
帕金森病运动并发症中西医结合诊治专.pdf
下载请点击:
评论区 (17)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=969476, encodeId=67349694e6d5, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf515128783, createdName=1464fd54m95暂无昵称, createdTime=Sat May 29 17:21:05 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962470, encodeId=95c19624e0d7, content=学习知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/3185e9276692465eadd57f4f81d1e29a/d4170dce84d243879ef1c4f173ad93b9.jpg, createdBy=9ef13604639, createdName=13331c94m86暂无昵称, createdTime=Mon May 03 17:33:19 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959213, encodeId=b153959213d4, content=学习好资料!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/978cb7a9bbc545b5b2a61273b2fd0754/498c401698c84f57b9a0a3efb1b8e4c0.jpg, createdBy=67a45482571, createdName=ms1000000056305151, createdTime=Wed Apr 21 22:59:11 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915747, encodeId=e495915e4758, content=写的太好啦,是很好学习资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f06d5311005, createdName=14889296m53暂无昵称, createdTime=Tue Jan 12 02:40:00 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915657, encodeId=de9291565e4e, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea405451913, createdName=ms1000001047552140, createdTime=Mon Jan 11 20:18:39 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
    2021-05-29 1464fd54m95暂无昵称

    👍👍

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=969476, encodeId=67349694e6d5, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf515128783, createdName=1464fd54m95暂无昵称, createdTime=Sat May 29 17:21:05 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962470, encodeId=95c19624e0d7, content=学习知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/3185e9276692465eadd57f4f81d1e29a/d4170dce84d243879ef1c4f173ad93b9.jpg, createdBy=9ef13604639, createdName=13331c94m86暂无昵称, createdTime=Mon May 03 17:33:19 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959213, encodeId=b153959213d4, content=学习好资料!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/978cb7a9bbc545b5b2a61273b2fd0754/498c401698c84f57b9a0a3efb1b8e4c0.jpg, createdBy=67a45482571, createdName=ms1000000056305151, createdTime=Wed Apr 21 22:59:11 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915747, encodeId=e495915e4758, content=写的太好啦,是很好学习资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f06d5311005, createdName=14889296m53暂无昵称, createdTime=Tue Jan 12 02:40:00 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915657, encodeId=de9291565e4e, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea405451913, createdName=ms1000001047552140, createdTime=Mon Jan 11 20:18:39 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
    2021-05-03 13331c94m86暂无昵称

    学习知识

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=969476, encodeId=67349694e6d5, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf515128783, createdName=1464fd54m95暂无昵称, createdTime=Sat May 29 17:21:05 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962470, encodeId=95c19624e0d7, content=学习知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/3185e9276692465eadd57f4f81d1e29a/d4170dce84d243879ef1c4f173ad93b9.jpg, createdBy=9ef13604639, createdName=13331c94m86暂无昵称, createdTime=Mon May 03 17:33:19 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959213, encodeId=b153959213d4, content=学习好资料!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/978cb7a9bbc545b5b2a61273b2fd0754/498c401698c84f57b9a0a3efb1b8e4c0.jpg, createdBy=67a45482571, createdName=ms1000000056305151, createdTime=Wed Apr 21 22:59:11 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915747, encodeId=e495915e4758, content=写的太好啦,是很好学习资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f06d5311005, createdName=14889296m53暂无昵称, createdTime=Tue Jan 12 02:40:00 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915657, encodeId=de9291565e4e, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea405451913, createdName=ms1000001047552140, createdTime=Mon Jan 11 20:18:39 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
    2021-04-21 ms1000000056305151

    学习好资料!!!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=969476, encodeId=67349694e6d5, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf515128783, createdName=1464fd54m95暂无昵称, createdTime=Sat May 29 17:21:05 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962470, encodeId=95c19624e0d7, content=学习知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/3185e9276692465eadd57f4f81d1e29a/d4170dce84d243879ef1c4f173ad93b9.jpg, createdBy=9ef13604639, createdName=13331c94m86暂无昵称, createdTime=Mon May 03 17:33:19 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959213, encodeId=b153959213d4, content=学习好资料!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/978cb7a9bbc545b5b2a61273b2fd0754/498c401698c84f57b9a0a3efb1b8e4c0.jpg, createdBy=67a45482571, createdName=ms1000000056305151, createdTime=Wed Apr 21 22:59:11 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915747, encodeId=e495915e4758, content=写的太好啦,是很好学习资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f06d5311005, createdName=14889296m53暂无昵称, createdTime=Tue Jan 12 02:40:00 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915657, encodeId=de9291565e4e, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea405451913, createdName=ms1000001047552140, createdTime=Mon Jan 11 20:18:39 CST 2021, time=2021-01-11, status=1, ipAttribution=)]
    2021-01-12 14889296m53暂无昵称

    写的太好啦,是很好学习资料

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=969476, encodeId=67349694e6d5, content=👍👍, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cf515128783, createdName=1464fd54m95暂无昵称, createdTime=Sat May 29 17:21:05 CST 2021, time=2021-05-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962470, encodeId=95c19624e0d7, content=学习知识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210517/3185e9276692465eadd57f4f81d1e29a/d4170dce84d243879ef1c4f173ad93b9.jpg, createdBy=9ef13604639, createdName=13331c94m86暂无昵称, createdTime=Mon May 03 17:33:19 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=959213, encodeId=b153959213d4, content=学习好资料!!!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=68, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210420/978cb7a9bbc545b5b2a61273b2fd0754/498c401698c84f57b9a0a3efb1b8e4c0.jpg, createdBy=67a45482571, createdName=ms1000000056305151, createdTime=Wed Apr 21 22:59:11 CST 2021, time=2021-04-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915747, encodeId=e495915e4758, content=写的太好啦,是很好学习资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=85, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f06d5311005, createdName=14889296m53暂无昵称, createdTime=Tue Jan 12 02:40:00 CST 2021, time=2021-01-12, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=915657, encodeId=de9291565e4e, content=<a href='/topic/show?id=a1f9485204d' target=_blank style='color:#2F92EE;'>#帕金森病#</a>共识, beContent=null, objectType=guider, channel=null, level=null, likeNumber=150, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=48520, encryptionId=a1f9485204d, topicName=帕金森病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea405451913, createdName=ms1000001047552140, createdTime=Mon Jan 11 20:18:39 CST 2021, time=2021-01-11, status=1, ipAttribution=)]